Trial Profile
Phase I trial of MAP 4343 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Apr 2016
Price :
$35
*
At a glance
- Drugs Pregnenolone methyl ether (Primary)
- Indications Brain injuries; Depressive disorders
- Focus Adverse reactions
- Sponsors Mapreg
- 25 Apr 2016 New trial record